EUCTR2016-001191-30-DK进行中（未招募）1 期
se of TachoSil® for the prevention of postoperative complications after groin dissection in vulva cancer patients
Department of Obstetrics & Gynecology, Copenhagen University Hospital, Rigshospitalet0 个研究点目标入组 70 人开始时间: 2017年3月3日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Women undergoing uni- or bilateral ILND for vulva cancer at Rigshospitalet, Denmark
- •Understand and speak Danish fluently
- •Written and oral informed consent
- •Written informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 15
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 55
排除标准
- •Women with previously diagnosed lymphedema of the legs
- •Known disease of the lymphatic system
- •Women who previously had a pelvic or paraaortic lymphadenectomy performed
- •Women who do not speak or read Danish
- •Active cancer at another cancer site
研究者
相似试验
进行中（未招募）
不适用
The use of Tachosil as sealant in the prevention of lymphorrea after surgical removal of lymph nodes for vulvar cancer: a clinical controlled prospective triallymphedema after groin lymphadenectomy in patients with vulvar cancerMedDRA version: 14.1Level: LLTClassification code 10025233Term: LymphedemaSystem Organ Class: 10047065 - Vascular disordersEUCTR2011-006059-13-ITA.O. UNIVERSITARIA INTEGRATA DI VERONA
招募中
不适用
The efficacy and safety of TachoSil as haemostatic treatment in robot assisted radical prostatectomyProstatic cancerJPRN-UMIN000015473Division of Urology, Department of Surgery, Tottori University Faculty of Medicine1,000
进行中（未招募）
1 期
Efficacy and safety of TachoSil in patients undergoing cystectomy. A pilot study. - TachoSil in urological surgeryThe trial will evaluate the efficacy and safety of TachoSil in patients undergoing cystectomy for bladder cancer and non-malignant bladder disease. TachoSil will be applied to the anastomoses between the ureters and the new bladder made of an isolated intestinal loop. The purpose of applying TachoSil to the anastomoses is to evaluate whether this treatment will reduce the degree of stenosis in the anastomoses and thus reduce the degree of impairment on the renal function.MedDRA version: 9.1Level: LLTClassification code 10005003Term: Bladder cancerEUCTR2007-003622-18-DKState University Hospital60
进行中（未招募）
不适用
The Safety and Feasibility of TachoSil® application on connections of the esophagus.Anastomotic leakageMedDRA version: 14.1Level: LLTClassification code 10065961Term: Esophageal anastomotic leakSystem Organ Class: 10022117 - Injury, poisoning and procedural complicationsMedDRA version: 14.1Level: LLTClassification code 10065890Term: Oesophageal anastomotic leakSystem Organ Class: 10022117 - Injury, poisoning and procedural complicationsEUCTR2011-005749-10-NLniversity Medical Center Utrecht
招募中
3 期
A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During SurgeryHemorrhageNCT06664775Corza Medical GmbH116